Task: Answer the multiple-choice question.
Question: Which drug exhibits a -39.599% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COc1ccc(NC(=O)N2CCC(n3nnc4cc(C)ccc43)CC2)cc1
[b] CC1CCN(c2ccc3nnc(CCC(=O)Nc4ccc(F)cc4)n3n2)CC1
Answer: b. CC1CCN(c2ccc3nnc(CCC(=O)Nc4ccc(F)cc4)n3n2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(c2ccc3nnc(CCC(=O)Nc4ccc(F)cc4)n3n2)CC1
CC1CCN(c2ccc3nnc(CCC(=O)Nc4ccc(F)cc4)n3n2)CC1
N-(4-fluorophenyl)-3-[6-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanamide